incb13739
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT00398619)
Timeline
Indications
Mechanism of action
HSD11B1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- incb013739
- incb13739
- incb13739
- incb13739
- incb13739
- incb 13739
- incb-13739
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00698230 | Phase 2 | May 1, 2008 | Incyte |
| NCT00478322 | Phase 2 | Apr 1, 2007 | Incyte |
| NCT00398619 | Phase 1 | Nov 1, 2006 | Incyte |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Incyte | For profit | 3 | 3 | 2 | 2006 |
1 organizations
Page 1 / 1